I didn't disagree. off label is and can be a massive market. look at ozempic for weight loss.
But the company can't come out and say we will get x percent from off label use. it is illegal for them to market or promote it.
70% is good. but x500-600% your revenue just on locking in refills is better and easier to scale across multiple products.
Ann: Botanix $40 Million Capital Raising for Sofdra Rollout, page-318
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.025(7.69%) |
Mkt cap ! $588.2M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 30.0¢ | $3.064M | 9.775M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 449742 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |